1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Shanghai Junshi Biosciences Co., Ltd.

Shanghai Junshi Biosciences Co., Ltd.

688180.SS
Shanghai Junshi Biosciences Co., Ltd.CN flagShanghai Stock Exchange
38.10
CNY
+0.11
- -
38.80BMarket Cap

Total Valuation

Shanghai Junshi Biosciences Co., Ltd. carries a market capitalization of 38.80B, placing it among publicly traded companies globally. Its enterprise value stands at 27.74B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap38.80B
Enterprise Value27.74B

Share Statistics

Shanghai Junshi Biosciences Co., Ltd. currently has 984.87M shares outstanding.

Shares Outstanding984.87M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 243.67, and the price-to-book ratio stands at -3.26.

PE RatioN/A
PS Ratio243.67
PB Ratio-3.26
P/TBV Ratio4.36
P/FCF Ratio35.58
P/OCF RatioN/A

Enterprise Valuation

EV / Sales238.38
EV / EBITDAN/A
EV / EBITN/A
EV / FCF33.77

Financial Position

Shanghai Junshi Biosciences Co., Ltd. maintains a current ratio of 2.07, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 38.79, indicating elevated leverage, while an interest coverage ratio of -41.20 demonstrates limited ability to service its debt obligations.

Current Ratio2.07
Quick Ratio1.42
Debt / Equity38.79
Debt / EBITDA-2.56
Interest Coverage-41.20

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-9.26
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.35

Taxes

Income Tax1.66M
Effective Tax RateN/A

Stock Price Statistics

Shanghai Junshi Biosciences Co., Ltd.'s stock has gained approximately 0.34237556% over the past 52 weeks. The 50-day moving average sits at 35.30, while the 200-day moving average is 36.41.

Beta (5Y)N/A
52-Week Price Change0.34237556%
50-Day Moving Average35.30
200-Day Moving Average36.41
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Shanghai Junshi Biosciences Co., Ltd. generated 116.35M in revenue and converted that into -1.06B in net income, yielding earnings per share of -1.15. EBITDA reached -1.01B, while operating income came in at -1.01B.

Revenue116.35M
Gross Profit575.26M
Operating Income-1.01B
Pretax Income-1.12B
Net Income-1.06B
EBITDA-1.01B
EBIT-1.01B
Earnings Per Share (EPS)-1.15

Balance Sheet

Shanghai Junshi Biosciences Co., Ltd. holds 3.31B in cash and equivalents against 2.57B in total debt, resulting in a net debt position of -170.94M. Total book value stands at -8.70B, with working capital of 2.49B providing operational flexibility.

Cash & Cash Equivalents3.31B
Total Debt2.57B
Net Debt-170.94M
Equity (Book Value)-8.70B
Book Value Per Share-8.92
Working Capital2.49B

Cash Flow

After subtracting -796.93M in capital expenditures, free cash flow totaled -796.93M - equivalent to -0.82 per share.

Operating Cash FlowN/A
Capital Expenditures-796.93M
Free Cash Flow-796.93M
FCF Per Share-0.82

Margins

Shanghai Junshi Biosciences Co., Ltd. operates with a gross margin of -81.17, reflecting its pricing power and cost economics. The operating margin of -863.84 and net profit margin of -907.66 provide insight into operational efficiency.

Gross Margin-81.17
Operating Margin-863.84
Pretax Margin-959.65
Profit Margin-907.66
EBITDA Margin-863.84

Dividends & Yields

The company's payout ratio of -1.16 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.01
Dividend YieldN/A
Payout Ratio-1.16
Shareholder Yield-3.39
FCF Yield2.81

Scores

Shanghai Junshi Biosciences Co., Ltd. posts an Altman Z-Score of 2.61, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.61